These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11142438)

  • 1. Misdiagnosis of antidepressant discontinuation symptoms.
    Haddad PM; Qureshi M
    Acta Psychiatr Scand; 2000 Dec; 102(6):466-7; discussion 467-8. PubMed ID: 11142438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nightmares and hallucinations after long-term intake of tramadol combined with antidepressants.
    Devulder J; De Laat M; Dumoulin K; Renson A; Rolly G
    Acta Clin Belg; 1996; 51(3):184-6. PubMed ID: 8766220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal hypomania associated with paroxetine.
    Landry P; Roy L
    J Clin Psychopharmacol; 1997 Feb; 17(1):60-1. PubMed ID: 9004064
    [No Abstract]   [Full Text] [Related]  

  • 4. Tricyclic antidepressants in adolescent depression. A case report.
    Evans CL; Ha Y; Saisch S; Ellison Z; Fombonne E
    Eur Child Adolesc Psychiatry; 1998 Sep; 7(3):166-71. PubMed ID: 9826304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delirium as a symptom of tricyclic antidepressant withdrawal.
    Alexander J; Berce G
    Aust N Z J Psychiatry; 2010 Sep; 44(9):863. PubMed ID: 20815675
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescribing of venlafaxine and dosulepin in primary care.
    McAllister-Williams RH; Foran K; Forrest S; Ingram G; McMahon L; Taylor M; Rajwal MS; Cornwall PL
    J Psychopharmacol; 2006 Nov; 20(6):868. PubMed ID: 17060347
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 12. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy.
    Lauritzen L; Odgaard K; Clemmesen L; Lunde M; Ohrström J; Black C; Bech P
    Acta Psychiatr Scand; 1996 Oct; 94(4):241-51. PubMed ID: 8911559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
    Pilhatsch M; Wolf R; Winter C; Lewitzka U; Bauer M
    J Affect Disord; 2010 Nov; 126(3):453-7. PubMed ID: 20547424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.
    Pollock BG; Laghrissi-Thode F; Wagner WR
    J Clin Psychopharmacol; 2000 Apr; 20(2):137-40. PubMed ID: 10770450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy.
    Diler RS; Tamam L; Avci A
    J Clin Psychopharmacol; 2000 Oct; 20(5):586-7. PubMed ID: 11001250
    [No Abstract]   [Full Text] [Related]  

  • 17. Focus on paroxetine.
    Green B
    Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation symptoms in depression and anxiety disorders.
    Baldwin DS; Montgomery SA; Nil R; Lader M
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):73-84. PubMed ID: 16359583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of nortriptyline plasma levels after cotreatment with paroxetine and thioridazine.
    Ghaemi SN; Kirkwood CK
    J Clin Psychopharmacol; 1998 Aug; 18(4):342-3. PubMed ID: 9690702
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of exposure to dothiepin and northiaden in breast milk on child development.
    Buist A; Janson H
    Br J Psychiatry; 1995 Sep; 167(3):370-3. PubMed ID: 7496646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.